Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs . placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1

Published 2017 View Full Article

Authors

Keywords

Journal

HAEMATOLOGICA

Volume 102, Issue 10, Pages 1767-1775

Publisher

Ferrata Storti Foundation (Haematologica)

Online

2017-07-28

DOI

10.3324/haematol.2017.170118

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

HAEMATOLOGICA

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Publish scientific posters with Peeref

Become a Peeref-certified reviewer